Samsung C&T got some good news this month as the company was listed on the 2020 Fortune Global 500. Ranked at 481, its 2020 Global 500 listing marked the fourth consecutive year for Samsung C&T to be selected. As opposed to the Fortune 500, which only relates to corporations based in

In difficult times, teamwork is the backbone of recovery. This fact has been emphasized more than ever by the COVID-19 pandemic as reflected in Samsung C&T’s newly published 2020 CSR Report. “COVID-19 served as an important reminder of the lesson that without harmonious cooperation with society and the environment, no enterprise

Samsung C&T’s efforts to improve profitability in addition to performance gains at subsidiary BioLogics have led to an increase in quarter-over-quarter (QoQ) operating profit, despite a drop in year-over-year (YoY) revenue due to COVID-19 and completion of large-scale projects, etc. KRW 7.223tn in revenue and KRW 238bn in operating profit,

Overall Performance Revenue: KRW 6.960tn, year-over-year (yoy) decrease by 397bn (5.4%) from 7.357tn in 1Q19 Operating Profit: KRW 147bn, yoy increase by 42bn (40.0%) from 105bn in 1Q19 Revenue fell as trading volume and domestic consumption decreased amid the COVID-19 situation, and as construction projects undertaken by the company reached

Samsung C&T held its 56th annual general shareholders’ meeting (AGM) in Seoul on March 20 for the fiscal year of 2019, with 73.4% of voting shares represented at the company’s headquarters in Seoul. The agenda included the approval of the full-year financial statement, appointment of board members, and cancellation of

Samsung C&T’s Board of Directors on February 26 approved a series of measures aimed at enhancing shareholder value and corporate governance: – New shareholder return policy (FY20-FY22 dividend policy, treasury share cancellation) – Measures to facilitate board-centric governance ① Appointment of 3 independent director candidates ② Strengthening of role and